Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Sep;27(9):1120-3.
doi: 10.3346/jkms.2012.27.9.1120. Epub 2012 Aug 22.

Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review

Ki Bae Kim  1 , Sun Moon Kim, Woori Park, Ji Seon Kim, Soon Kil Kwon, Hye-Young Kim
Affiliations
Case Reports

Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review

Ki Bae Kim et al. J Korean Med Sci. 2012 Sep.

Abstract

Ceftriaxone is widely used in patients for the treatment of serious gram-negative infections. Ceftriaxone can induce some potential side effects, including neurotoxicity, however, nonconvulsive status epilepticus has rarely been reported. We report a case of acute reversible neurotoxicity associated with ceftriaxone. A 65-yr-old woman with chronic kidney disease developed altered consciousness during ceftriaxone treatment for urinary tract infection. The electroencephalogram demonstrated continuous bursts of generalized, high-voltage, 1 to 2 Hz sharp wave activity. Neurologic symptoms disappeared following withdrawal of ceftriaxone. The possibility of ceftriaxone-induced neurotoxicity should be considered in patients developing neurological impairment during ceftriaxone use, and the discontinuation of the drug could lead to complete neurological improvement.

Keywords: Ceftriaxone; Cephalosporins; Chronic Kidney Failure; Seizures.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Electroencephalogram (EEG) findings during nonconvulsive status epilepticus and recovery state. (A) EEG on day 22, when the patient presented an altered mental state. An EEG showed generalized slowing of the background with superimposed almost continuous bursts of generalized, moderate to high amplitude that had an almost periodic pattern (arrows). (B) EEG on day 24, when the patient's neurologic symptoms resolved completely. Epileptiform discharges had disappeared.
Fig. 2
Fig. 2
Abdomen/Pevis CT showing the extensive thrombosis (arrowheads). (A) Thrombosis in the inferior vena cava. (B) Thrombosis in the renal vein.
See this image and copyright information in PMC

References

    1. Rockowitz J, Tunkel AR. Bacterial meningitis. Practical guidelines for management. Drugs. 1995;50:838–853. - PubMed
    1. Weisfelt M, de Gans J, van de Beek D. Bacterial meningitis: a review of effective pharmacotherapy. Expert Opin Pharmacother. 2007;8:1493–1504. - PubMed
    1. Patel IH, Sugihara JG, Weinfeld RE, Wong EG, Siemsen AW, Berman SJ. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother. 1984;25:438–442. - PMC - PubMed
    1. Martinez-Rodriguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, dela Rosa CR. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med. 2001;111:115–119. - PubMed
    1. Sato Y, Morita H, Wakasugi H, Iijima S, Kawashima E, Wakayama Y, Yoshimura A. Reversible chreoathetosis after the administration of ceftriaxone sodium in patients with end-stage renal disease. Am J Med Sci. 2010;340:382–384. - PubMed

Publication types

MeSH terms

LinkOut - more resources